Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.
作者信息
Senn H J, Jungi W F, Amgwerd R, Sprenger F, Hochueli R, Engelhart G, Heinz C, Wick A, Enderlin F, Creux G, Simeon B, Lanz R, Bigler R
出版信息
Antibiot Chemother (1971). 1978;24:213-28.
PMID:350137
Abstract
摘要
相似文献
1
2
3
Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.
Eur J Cancer (1965). 1980;Suppl 1:169-72.
4
Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.在淋巴结阴性和阳性乳腺癌中使用LMF联合卡介苗进行辅助化学免疫治疗——4年中期报告
Recent Results Cancer Res. 1982;80:177-84. doi: 10.1007/978-3-642-81685-7_29.
5
Swiss adjuvant trials in women with node-negative breast cancer. OSAKO.瑞士针对淋巴结阴性乳腺癌女性的辅助治疗试验。大坂。
J Natl Cancer Inst Monogr. 1992(11):71-6.
6
Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results.在淋巴结阴性和阳性乳腺癌患者中采用LMF联合卡介苗进行辅助化学免疫治疗：10年结果
Eur J Cancer Clin Oncol. 1989 Mar;25(3):513-25. doi: 10.1016/0277-5379(89)90265-4.
7
Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.在淋巴结阴性和阳性乳腺癌中使用LMF+卡介苗进行辅助化学免疫治疗。
Haematol Blood Transfus. 1978;22:47-60. doi: 10.1007/978-3-642-67111-1_5.
8
Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.
Recent Results Cancer Res. 1984;96:90-101. doi: 10.1007/978-3-642-82357-2_11.
9
[Adjuvant chemotherapy in breast cancer: status in 1984].
Wien Klin Wochenschr. 1984 Jun 22;96(13):486-92.
10
Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).原发性乳腺癌中使用苯丁酸氮芥和5-氟尿嘧啶的辅助化疗（海德堡合作研究）
Eur J Cancer (1965). 1980;Suppl 1:157-60.
Zotero 插件